Are eosinophils still important in asthma?

Clinical and Experimental Allergy

Volumn 31, Issue 4, 2001, Pages 525-528

  Chu, H W ^a   Martin, R J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALLERGEN; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; MAJOR BASIC PROTEIN; METHACHOLINE; PEPTIDOLEUKOTRIENE; POLYMYXIN B; PROSTACYCLIN; PROSTAGLANDIN E2;

ALLERGIC ASTHMA; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CELL ACTIVATION; CELL COUNT; CELL SURVIVAL; CELL TRANSPORT; CELL TYPE; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; EDITORIAL; EOSINOPHIL; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HOUSE DUST ALLERGY; HUMAN; LOEFFLER PNEUMONIA; MAST CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ASTHMA; BRONCHI; EOSINOPHILS; HUMANS; POLYMYXIN B;

EID: 0035725068     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01095.x     Document Type: Editorial

References (40)

1. Airway remodeling and repair
2. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
3. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline
4. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness
5. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity
6. Activated T cells and eosinophilia in broochoalveolar lavages from subjects with asthma correlated with disease severity
7. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
8. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness
9. Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma
10. In vivo airway eosinophil accumulation induced by pdlymyxin-B reduces bronchial responsiveness in guinea pigs
11. The pathology of bronchial asthma
12. Death in asthmatics
13. A clinical and pathological study of fatal cases of status asthmaticus
14. Eosinophilic inflammation in asthma
15. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and broanhoalveolar lavage (BAL) of asthmatic patients after allergen inhalation
16. T cells and eosinophils in the pathogenesis of asthma
17. Alveolar tissue inflammation in asthma
18. Changes in sputum eosinophils predict loss of asthma control
19. Severity of exereise-induced bronchoeonstriction is related to airway eosinophilic inflammation in patients with asthma
20. Human eoEmophil-granule major basic protein and synthetic polycations induce airway hytxm'csponsivencas in vivo dependent on bradykinin generation
21. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation
22. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects
23. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators
24. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma
25. Role of IL-5 in the development of allergen-ioducod airway hyperresponsiveness
26. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma
27. Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity
28. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids
29. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
30. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection
31. Inhibition of pulmonary eosinophilia does not necessarily prevent the airway hyperresponsiveness induced by Sephadex beads
32. Airway structure and inflammatory cells in fatal attacks of asthma
33. Mucosal inflammation in severe glucocorticoid-dependent asthma
34. 240563, A humanised anti-IL-5 monoclonal antibody: Initial single dose safety and activity in patients with asthma
35. Late asthmatic reaction with airway inflammation but without airway hyperresponsiveness
36. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs
37. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge
38. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation
39. Specific receptors for prostaglandins in airways
40. The role of eosinophils and neutrophils in inflammation